Vertex Pharmaceuticals' new $200,000-a-year cystic fibrosis drug could help 90% of patients breathe. It's an amazing--and profitable--innovation. But will that windfall spur the 28-year-old startup to do it again?
from Forbes Real Time http://www.forbes.com/sites/matthewherper/2017/08/08/vertex-pharmaceuticals-and-the-price-of-inspiration/
via IFTTT
No comments:
Post a Comment